| Literature DB >> 34255238 |
Kyung-Jin Park1, Thomas Meißner1, Elena Günther2, Gerhard Schmalz1, Tanja Kottmann3, Felix Krause4, Rainer Haak1, Dirk Ziebolz5.
Abstract
This study aimed at evaluating the effectiveness of an adjuvant chlorhexidine-fluoride varnish (Cervitec F) for prevention and arrest of root caries on elderly participants using quantitative light-induced fluorescence (QLF). 23 participants with two or three non-cavitated root carious lesions were included and assigned to three groups of different varnishes (CF: Cervitec F, P: placebo, DP: Duraphate). Agents were applied once to root surface at baseline and in follow-up after 3, 6 and 9 months. The lesions were assessed clinically and with QLF. QLF-images were analyzed regarding fluorescence loss (ΔF), lesion volume (ΔQ) and bacterial activity (ΔR) before (t0), after 14 days (t1), 6- (t2) and 12-months (t3). CF showed a significant difference between t0 and t3: ∆F (- 12.51 [15.41] vs. - 7.80 [16.72], p = 0.012), ∆Q (- 2339.97 (20,898.30) vs. - 751.82 (5725.35), p < 0.001), ∆R (23.80 [41.70] vs. 7.07 [37.50], p = 0.006). Independently of the varnish application, preventive care seems positively influence the root caries progress. Although within CF group the strongest effect was observed, no superiority of a specific varnish application was confirmed over a 12-months QLF observation period. Extra topical fluoride can help remineralise dentin lesions and QLF can be used as a measurement method to determine changes in the dentin lesions.Entities:
Keywords: Chlorhexidine–fluoride varnish; Clinical trial; Quantitative light-induced fluorescence; Root caries
Mesh:
Substances:
Year: 2021 PMID: 34255238 PMCID: PMC8732822 DOI: 10.1007/s10266-021-00637-w
Source DB: PubMed Journal: Odontology ISSN: 1618-1247 Impact factor: 2.634
Fig. 1Participant flow through the randomized clinical trial (RCT) according to the CONSORT guidelines
Patients characteristics
| Total | CF group | P group | DP group | ||
|---|---|---|---|---|---|
| Number of teeth ( | 61 (100) | 23 (37.7) | 23 (37.7) | 15 (24.6) | – |
| Gender ( | |||||
| Female | 27 (44) | 10 (43) | 10 (43) | 7 (46) | |
| Male | 34 (56) | 13 (57) | 13 (57) | 8 (54) | |
| Age in years (mv ± sd) | 68.25 ± 10.46 | 68.04 ± 10.62 | 68.04 ± 10.62 | 68.87 ± 10.70 | |
| Visual inspection score ( | |||||
| Score 1 | 45 (74) | 18 (78) | 16 (70) | 11 (73) | |
| Score 2 | 16 (26) | 5 (22) | 7 (30) | 4 (27) | |
| Salivary flow rate ( | |||||
| Un-stimulated | 1.00 ± 0.74 | 0.98 ± 0.75 | 0.98 ± 0.75 | 1.05 ± 0.76 | |
| Stimulated | 5.18 ± 2.95 | 5.15 ± 3.02 | 5.15 ± 3.02 | 5.26 ± 2.96 | |
| Reduced salivary flow ( | 0 | 0 | 0 | 0 | – |
| Salivary buffer capacity ( | |||||
| Low | 3 (6) | 1 (4) | 1 (4) | 1 (7) | |
| Medium | 17 (32) | 6 (26) | 6 (26) | 5 (33) | |
| High | 33 (62) | 13 (70) | 13 (70) | 7 (60) | |
mv mean value, sd standard deviation
*CRT buffer Test, IvoclarVivadent, Schaan Liechtenstein
Allocation of groups and procedure for application of used materials according to manufacturer’s recommendations
| Material | Composition | Application |
|---|---|---|
| CF group | Alcohol/aqua (80–90 wt.-%) Vinylacetat/crotonates copolymer Cetylpyridinium chloride (0.5%) Chlorhexidine diacetate (0.3%) Ammonium fluoride (fluoride content: 1400 ppm) aroma saccharin | Three-monthly application of Cervitec F 1. Isolation of the application area with cotton rolls 2. Applying the varnish once in a thin layer using a brush 3. Drying varnish for 1 min 4. Removing the cotton rolls Application of fluoride-containing toothpaste (twice per day, for 2 min.; 1250 ppm, Dentagard, Colgate Oral Pharmaceutical, Inc, Canton MA, USA) |
Cervitec F (Ivoclar Vivadent AG, Schaan, Lichtstein) | ||
| P group | Alcohol/aqua (80–90 wt.-%) Vinyl acetate/crotonates copolymer Aroma Saccharin | Three-monthly application of placebo 1. Isolation of the application area with cotton rolls Applying the agent once in a thin layer using a brush Drying varnish for 1 min. 4. Removing the cotton rolls Application of fluoride-containing toothpaste (twice per day, for 2 min.; 1250 ppm, Dentagard, Colgate) |
Placebo (Ivoclar Vivadent AG, Schaan, Lichtstein) | ||
| DP group | Colophonium Ethanol Sodium fluoride (fluoride content: 22,600 ppm) saccharin Isoamyl acetate Mastic Shellac Bleached wax | Three-monthly application of Duraphat 1. Isolation of the application area with cotton rolls 2. Applying the varnish once in a thin layer using cotton swabs 3. Drying varnish for 1 min 4. Removing the cotton rolls Application of fluoride-containing toothpaste (twice per day, for 2 min.; 1250 ppm, Dentagard, Colgate) |
Duraphat (Colgate Oral Pharmaceutical, Inc, Canton MA, USA) |
Distribution of included teeth between groups
| Total ( | CF group ( | P group ( | DP group ( | |
|---|---|---|---|---|
| Anterior maxilla | 19 | 9 | 8 | 2 |
| Premolar maxilla | 6 | 1 | 3 | 2 |
| Anterior mandible | 24 | 8 | 8 | 8 |
| Premolar mandible | 12 | 5 | 4 | 3 |
Fig. 2Workflow
Results for ΔF, ΔQ and ∆R depending on examination time of groups (median [IQR])
| CF group | P group | DP group | |
|---|---|---|---|
| Δ | |||
| Baseline | − 12.51 (15.41) | − 10.35 (10.06) | − 11.04 (19.45) |
| | − 11.25 (10.92) | − 8.93 (11.99) | − 8.95 (24.90) |
| | − 9.91(15.06) | − 7.62 (12.82) | − 8.53 (15.28) |
| | − 7.80 (16.72)* | − 9.17 (8.65) | − 7.81 (20.00) |
| | 0.008 | 0.037 | 0.066 |
| Δ | |||
| Baseline | − 2339.97 (20,898.30) | − 1382,91 (18,459,39) | − 1721.30 (4869.73) |
| | − 1851.40 (15,683.66) | − 1184.65 (10,424,66) | − 1796.66 (21,060.01) |
| | − 417.13 (4329.76)* | − 1273.42 (10,354,86) | − 922.72 (15,257.73) |
| | − 751.82 (5725.35)* | − 1301.23 (15,230,32) | − 989.45 (11,894.92) |
| | < 0.001 | 0.015 | 0.113 |
| Δ | |||
| Baseline | 23.80 (41.70) | 25.00 (45.43) | 16.27 (36.37) |
| | 27.47 (32.44) | 25.57 (35.70) | 22.27 (46.83) |
| | 17.97 (36.83) | 23.47 (36.83) | 24.70 (39.20) |
| | 7.07 (37.50)* | 24.83 (33.03) | 7.37 (43.17) |
| | < 0.001 | 0.001 | 0.006 |
IQR inter-quartile-range
*Significant finding in post-hoc analysis in comparison to baseline (p < 0.05)
Comparison of the three study parameters (median ΔF, ΔQ und ΔR) between groups from Baseline to t1, t2 and t3
| Parameter/time point | CF group | P group | DP group | |
|---|---|---|---|---|
| Δ | ||||
| | − 0.97 | 0 | 0 | 0.552 |
| | − 3.34 | − 2.19 | 0 | 0.324 |
| | − 3.41 | − 1.46 | − 2.25 | 0.320 |
| Δ | ||||
| | − 1314.50 | 0 | 0 | 0.178 |
| | − 1692.09 | − 482.25 | − 194.80 | 0.535 |
| | − 1588.15 | − 731.24 | − 194.80 | 0.903 |
| Δ | ||||
| | 0 | − 0.23 | 0 | 0.574 |
| | 4.40 | 1.77 | 0 | 0.185 |
| | 7.77 | 0.50 | 7.53 | 0.115 |
Comparison of the difference of measured parameters (median ΔF, ΔQ und ΔR) between groups from Baseline to t1, t2 and t3 under consideration of the visual inspection score
| Parameter/time point | CF group | P group | DP group | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Score 1 ( | Score 2 ( | Score 1 ( | Score 2 ( | Score 1 ( | Score 2 ( | CF vs. P | CF vs. DP | P vs. DP | ||
| ΔF (%) | ||||||||||
| | − 0.70 | − 2.47 | 0 | − 1.57 | − 0.76 | 4.69 | 0.069 | – | – | – |
| | − 3.23 | − 3.57 | − 1.60 | − 2.41 | − 1.75 | 0.71 | 0.652 | – | – | – |
| | − 2.79 | − 4.99 | − 0.80 | − 2.49 | − 2.25 | − 1.56 | 0.134 | – | – | – |
| ΔQ (% µm2) | ||||||||||
| | − 786.15 | − 8967.47 | 32.27 | − 6143.83 | 0 | 7318.90 | 0.016 | 0.624 | 0.057 | 0.138 |
| | − 1652.52 | − 11,560.54 | − 344.30 | − 3133.15 | − 194.80 | − 4864.97 | 0.889 | – | – | – |
| | − 1428.61 | − 13,390.54 | − 476.63 | − 5218.28 | − 194.80 | 3956.53 | 0.785 | – | – | – |
| Δ | ||||||||||
| | 0 | 6.07 | − 0.12 | − 2.83 | 0.57 | − 16.83 | 0.038 | 0.269 | 0.732 | 0.520 |
| | 4.78 | 3.63 | 1.65 | 4.23 | 0 | − 7.33 | 0.773 | – | – | – |
| | 6.30 | 11.17 | 0.10 | 8.17 | 7.53 | 24.72 | 0.417 | – | – | – |